ADCT
ADC Therapeutics S.A.
NYSE · Healthcare · Biotechnology · CH
$1.35
+1.89%Margins
Gross margin
88.7%
EBITDA margin
-111.1%
EBIT margin
-125.8%
Net margin
-123.0%
FCF margin
-129.9%
42.5%
Return on equity
-34.7%
Return on assets
-52.5%
Return on invested capital
0.28x
Asset turnover
-$102.3M
Cash from operations
$1.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026